Amwell® adds Vida to its clinical programs portfolio expanding access to obesity and diabetes care
Vida to offer cardiometabolic solutions including GLP-1s and other anti-obesity medications on the Amwell platform
The program, Amwell Cardiometabolic Care Powered by Vida, will be available to Amwell’s expansive client footprint of health plans and employers. Clients will be able to offer their members access to a suite of cardiometabolic care, including obesity, diabetes prevention and management, and behavioral health support. The program will tailor care based on social factors such as food security, financial barriers, cultural norms, and beliefs. Vida’s services are available on the Amwell platform alongside existing virtual primary care, urgent care, behavioral health and other clinical programs in the Amwell ecosystem.
“We are thrilled to partner with Amwell,” said
More than 40 percent of American adults struggle with obesity, a condition that increases the risk of developing diabetes, heart disease and cancer. Together, obesity and diabetes cost the
Vida clinicians prescribe GLP-1s, other anti-obesity medications and lifestyle interventions like Medical Nutrition Therapy. These services are delivered through a value-based, outcomes-driven model that ensures accountability and measurable results.
“We’re pleased Vida is joining the growing number of third-party programs available through Amwell’s integrated clinical solutions portfolio. With this partnership, our health plan clients can offer members a single entry point to the clinical and behavioral health support they need for obesity care and related illnesses,” said
Amwell’s clinical programs portfolio features virtual and digital care products from partners addressing various health conditions. The portfolio is part of the company’s platform and provides health plans with the technology to offer employers and members a unified and delightful entry point to a comprehensive and dynamic set of orchestrated clinical programs. The result is a personalized and reportable whole-person care model focused on improving health outcomes and driving efficiencies.
About
About Amwell
Amwell is a leading hybrid care delivery enablement platform in
©2025
![]()
Media:Vida Health Mim Harwood Miriam.Harwood@vida.com AmwellAngela Vogen Press@amwell.com Investors:Sue Dooley Sue.Dooley@amwell.com (415) 602-9167